Literature DB >> 19061072

Mechanisms underlying the opposing effects of P2Y receptors on the cell cycle.

Ravi Pathak1, Sonika Bhatnagar, Ashok Kumar Dubey.   

Abstract

The purinergic P2Y receptors are critical determinants of physiological function playing diverse roles in cell proliferation, differentiation, and survival. However, in cancer cells they have been reported to assume contradictory roles at times, thus causing inhibition of proliferation, cell death, and apoptosis. A critical evaluation and analysis of the existing experimental data show that this response is caused by multiple mechanisms at the level of the ligand, receptor, G protein, intracellular signaling, such as the mitogen activated protein kinase pathways and surface expression. This review addresses the impact of these factors in determining the outcome of P2Y receptor activation. Working in conjunction, these factors can act to produce the observed opposing effects on the cell cycle. Thus, they are important factors in the pathogenesis and control of cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19061072     DOI: 10.1080/10799890802539559

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  3 in total

Review 1.  Purinergic signalling and cancer.

Authors:  Geoffrey Burnstock; Francesco Di Virgilio
Journal:  Purinergic Signal       Date:  2013-12       Impact factor: 3.765

2.  Transformation by a nucleotide-activated P2Y receptor is mediated by activation of Galphai, Galphaq and Rho-dependent signaling pathways.

Authors:  Anurag Singh; José L Boyer; Channing J Der; Irene E Zohn
Journal:  J Mol Signal       Date:  2010-07-23

3.  Adenosine/TGFβ axis in regulation of mammary fibroblast functions.

Authors:  Georgii Vasiukov; Anna Menshikh; Philip Owens; Tatiana Novitskaya; Paula Hurley; Timothy Blackwell; Igor Feoktistov; Sergey V Novitskiy
Journal:  PLoS One       Date:  2021-06-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.